<SEC-DOCUMENT>0001214659-21-002012.txt : 20210217
<SEC-HEADER>0001214659-21-002012.hdr.sgml : 20210217
<ACCEPTANCE-DATETIME>20210217064551
ACCESSION NUMBER:		0001214659-21-002012
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20210217
DATE AS OF CHANGE:		20210217

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ault Global Holdings, Inc.
		CENTRAL INDEX KEY:			0000896493
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC COMPONENTS, NEC [3679]
		IRS NUMBER:				941721931
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-251995
		FILM NUMBER:		21642598

	BUSINESS ADDRESS:	
		STREET 1:		11411 SOUTHERN HIGHLANDS PARKWAY
		STREET 2:		SUITE 240
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89141
		BUSINESS PHONE:		(949) 444-5464 3679

	MAIL ADDRESS:	
		STREET 1:		11411 SOUTHERN HIGHLANDS PARKWAY
		STREET 2:		SUITE 240
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89141

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DPW Holdings, Inc.
		DATE OF NAME CHANGE:	20171229

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIGITAL POWER CORP
		DATE OF NAME CHANGE:	19960823
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>a216210424b5.htm
<DESCRIPTION>AMENDMENT NO. 1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Filed Pursuant
to Rule&nbsp;424(b)(5)<BR>
Registration No.&nbsp;333-251995</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>AMENDMENT NO. 1 DATED FEBRUARY 17, 2021 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>To Prospectus Supplement dated January 25, 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(To Prospectus dated January 20, 2021)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;<IMG SRC="aultglobal_biglogo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ault Global Holdings, Inc.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to $125,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>__________________________________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Amendment No.&nbsp;1
to Prospectus Supplement, or this amendment, amends our prospectus supplement dated January 25, 2021, or the prospectus supplement.&nbsp;This
amendment should be read in conjunction with the prospectus supplement and the prospectus dated January 20, 2021, both of which
are to be delivered with this amendment.&nbsp;This amendment amends only those sections of the prospectus supplement listed in
this amendment; all other sections of the prospectus supplement remain as is.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 22, 2021,
we entered into an At-The-Market Issuance Sales Agreement, or the sales agreement, with Ascendiant Capital Markets, LLC, or the
sales agent, relating to the sale of shares of our common stock, $0.001 par value per share, offered by this prospectus supplement
and the accompanying prospectus, as amended by the amendment to the sales agreement dated February 16, 2021, or the amended sales
agreement. In accordance with the terms of the amended sales agreement, we may offer and sell shares of our common stock having
an aggregate offering price of up to $125,000,000 (which amount includes shares we have already sold pursuant to the sales agreement
prior to the date of this amendment) from time to time through the sales agent. As of February 12, 2021, we have sold an aggregate
of 10,086,400 shares of our common stock pursuant to the sales agreement for gross proceeds of $49,978,352.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales of our common
stock, if any, under this prospectus supplement will be made by any method permitted that is deemed an &ldquo;at the market offering&rdquo;
as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended, or the Securities Act. The sales agent is not required
to sell any specific amount, but will act as our sales agent using commercially reasonable efforts consistent with its normal trading
and sales practices. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
traded on the NYSE American under the symbol &ldquo;DPW.&rdquo; The sale price of our common stock on February 12, 2021 was $5.66
per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of February 12,
2021, the aggregate market value of our outstanding common stock held by non-affiliates, or the public float, was $209,073,002,
which was calculated based on 38,023,176 shares of our outstanding common stock held by non-affiliates at a price of $5.66 per
share, the closing price of our common stock on that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The sales agent will
be entitled to compensation at a commission rate of 3.25% of the gross sales price per share sold. In connection with the sale
of the common stock on our behalf, the sales agent will be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the
Securities Act and the compensation of the sales agent will be deemed to be underwriting commissions or discounts. We have also
agreed to provide indemnification and contribution to the sales agent with respect to certain liabilities, including liabilities
under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a smaller reporting
company under Rule 405 of the Securities Act and, as such, have elected to comply with certain reduced public company reporting
requirements for this prospectus supplement, the documents incorporated by reference herein and future filings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>__________________________________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investing in our
common stock involves a high degree of risk. Before buying shares of our common stock, you should carefully consider the risk factors
described in &ldquo;Risk Factors&rdquo; beginning on page&nbsp;S-2 of this amendment and under similar headings in the prospectus
supplement dated January 25, 2021 and other documents incorporated by reference into the prospectus supplement, the accompanying
prospectus, and any free writing prospectus that we have authorized for use in connection with this offering.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the U.S.
Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities, or determined
if this prospectus supplement or the accompanying prospectus is accurate or complete. Any representation to the contrary is a criminal
offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="acmsm_smlogo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this Amendment No. 1 to Prospectus
Supplement is February 17, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amendment No. 1 to Prospectus Supplement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 95%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#about"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">About this Amendment to Prospectus Supplement</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#special"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special Note Regarding Forward-Looking Information</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#theoffering"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Offering</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#riskfactors"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-2</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#useofproceeds"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-3</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#dilution"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#planofdist"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of Distribution</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-5</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#legalmatters"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Matters</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-6</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>We have not, and
the sales agent has not, authorized anyone to provide you with information different than that which is contained in or incorporated
by reference in this amendment, the prospectus supplement, the accompanying prospectus, and in any free writing prospectus that
we have authorized for use in connection with this offering. We are not, and the sales agent is not, making an offer to sell these
securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this
amendment, the prospectus supplement, the accompanying prospectus, the documents incorporated by reference in this amendment, and
in any free writing prospectus that we have authorized for use in connection with this offering, is accurate only as of the date
of those respective documents. Our business, financial condition, results of operations and prospects may have changed since those
dates. You should read this amendment, the prospectus supplement, the accompanying prospectus, the documents incorporated by reference
in this amendment, and any free writing prospectus that we have authorized for use in connection with this offering, in their entirety
before making an investment decision. You should also read and consider the information in the documents to which we have referred
you in the sections of the prospectus supplement and the accompanying prospectus titled &ldquo;Where You Can Find More Information&rdquo;
and &ldquo;Incorporation of Certain Documents by Reference.&rdquo;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>For investors outside
the United States: We have not and the sales agent has not done anything that would permit this offering or possession or distribution
of this amendment, the prospectus supplement or the accompanying prospectus in any jurisdiction where action for that purpose is
required, other than in the United States. Persons outside of the United States who come into possession of this amendment or the
prospectus supplement and the accompanying prospectus must inform themselves about, and observe any restrictions relating to, the
offering of the shares of common stock and the distribution of this amendment, the prospectus supplement or the accompanying prospectus
outside of the United States.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="about"></A><B>ABOUT THIS AMENDMENT TO PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This amendment, the
prospectus supplement and the accompanying prospectus are part of a registration statement that we filed with the U.S. Securities
and Exchange Commission (the &ldquo;SEC&rdquo;), using a &ldquo;shelf&rdquo; registration process on Form S-3 (File No. 333-251995),
and that was declared effective by the SEC on January 20, 2021. Under the prospectus supplement dated January 25, 2021, as amended
by this amendment, we may offer shares of our common stock having an aggregate sales price of up to $125 million (which amount
includes the value of the shares we have already sold prior to the date of this amendment) from time to time at prices and on terms
to be determined by market conditions at the time of offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This amendment describes
the specific details regarding this offering, including the price, the amount of our common stock being offered, certain risks
of investing in our common stock and other items. You should read this entire amendment, the prospectus supplement, as well as
the accompanying prospectus, together with the additional information described therein under the headings &ldquo;Incorporation
of Certain Documents by Reference&rdquo; and &ldquo;Where You Can Find More Information&rdquo; carefully before making an investment
decision. Generally, when we refer to this prospectus, we are referring to both parts of this document combined.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent there
is a conflict between the information contained in this amendment, on the one hand, and the information contained in the prospectus
supplement and the accompanying prospectus or in any document incorporated by reference that was filed with the SEC before the
date of this prospectus supplement, on the other hand, you should rely on the information in this amendment. If any statement in
one of these documents is inconsistent with a statement in another document having a later date - for example, a document incorporated
by reference in the accompanying prospectus - the statement in the document having the later date modifies or supersedes the earlier
statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should assume that
the information contained in this amendment is accurate as of the date on the front cover of this amendment only and that any information
we have incorporated by reference or included in the accompanying prospectus is accurate only as of the date given in the document
incorporated by reference or as of the date of the prospectus, as applicable, regardless of the time of delivery of this amendment,
the prospectus supplement or the accompanying prospectus or any sale of our common stock. Our business, financial condition, liquidity,
results of operations and prospects may have changed since that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All references to &ldquo;we,&rdquo;
&ldquo;us,&rdquo; &ldquo;our,&rdquo; the &ldquo;company&rdquo; and &ldquo;AGH&rdquo; mean Ault Global Holdings, Inc. (formerly
known as DPW Holdings, Inc.), including its subsidiaries, except where it is clear that the term refers only to Ault Global Holdings,
Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This amendment, the
prospectus supplement, the accompanying prospectus, and the information incorporated herein and thereby by reference include trademarks,
service marks and tradenames owned by us or other companies. All trademarks, service marks and tradenames included or incorporated
by reference in this amendment, the prospectus supplement or the accompanying prospectus are the property of their respective owners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="special"></A><B>SPECIAL NOTE REGARDING FORWARD-LOOKING
INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 27A of the
Securities Act of 1933, as amended, (the &ldquo;Securities Act&rdquo;) and Section 21E of the Securities Exchange Act of 1934,
as amended, (the &ldquo;Exchange Act&rdquo;), provide a &ldquo;safe harbor&rdquo; for forward-looking statements to encourage companies
to provide prospective information about their companies. We intend such forward-looking statements to be covered by the safe harbor
provisions for forward-looking statements contained in the United States Private Securities Litigation Reform Act of 1995. All
statements, other than statements of historical facts, included or incorporated by reference in this amendment, the prospectus
supplement and the accompanying prospectus regarding our strategy, future operations, financial position, future revenues, projected
costs, prospects, plans and objectives of management, including, without limitation, the discussion of changes and expectations
concerning DPW&rsquo;s business operations during the COVID-19 pandemic, expectations regarding financing, and expectations concerning
DPW&rsquo;s business strategy are forward-looking statements that involve risks and uncertainties. In some cases, you can identify
forward-looking statements by our use of words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; &ldquo;could,&rdquo;
&ldquo;should,&rdquo; &ldquo;projects&rdquo; &ldquo;believes,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo;
&ldquo;estimates,&rdquo; &ldquo;forecast,&rdquo; &ldquo;potential,&rdquo; &ldquo;thinks,&rdquo; &ldquo;intends,&rdquo; &ldquo;likely,&rdquo;
&ldquo;continue,&rdquo; &ldquo;pursue,&rdquo; &ldquo;strategy&rdquo; or &ldquo;future,&rdquo; or the negative of these words or
other words or expressions of similar meaning. These statements are only predictions. Such statements are based on currently available
operating, financial and competitive information, and are subject to inherent risks, uncertainties and changes in circumstances
that are difficult to predict and many of which are outside of our control. Future events and our actual results and financial
condition may differ materially from those reflected in these forward-looking statements. Therefore, you should not place undue
reliance on our forward-looking statements. There are a number of important factors that could cause our actual results, performance,
achievements or industry to differ materially from those indicated by these forward-looking statements. These important factors
include the factors that we identify under the heading &ldquo;Risk Factors&rdquo; and elsewhere in this amendment, the prospectus
supplement and the accompanying prospectus. Our forward-looking statements are based on our current expectations, intentions and
beliefs as of the date of this amendment or the date of the documents incorporated by reference in this amendment, as the case
may be, and except as required by federal securities laws, we do not undertake, and specifically decline, any obligation to update
any of these statements or to publicly announce the results of any revisions to these statements to reflect future events or developments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="theoffering"></A><B>THE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>The following summary
contains general information about this offering. The summary is not intended to be complete. You should read the full text and
more specific details contained elsewhere in this amendment, the prospectus supplement and the accompanying prospectus.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock offered by us pursuant to this <BR>
amendment</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 70%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares of our common stock having
an aggregate offering price of up to $125 million, which includes approximately $49.98 million in gross proceeds from the prior
sale of common stock under the sales agreement.</P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of distribution</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our&nbsp;&ldquo;At the market
offering&rdquo; that may be made from time to time on the NYSE American or other market for our common stock in the United States
through the sales agent. See the section titled &ldquo;Plan of Distribution&rdquo; on page S-4 of this amendment.</P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to use the net proceeds
of this offering to finance our growth strategy and for working capital and general corporate purposes. See the section titled
&ldquo;Use of Proceeds&rdquo; on page S-2 of this amendment.</P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See the section titled &ldquo;Risk
Factors&rdquo; beginning on page S-2 of this amendment, page S-5 of the prospectus supplement, and the other information included
in, or incorporated by reference into this amendment for a discussion of certain factors you should carefully consider before
deciding to invest in shares of our common stock.</P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE American symbol</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DPW</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="riskfactors"></A><B>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>An investment in
our common stock involves a high degree of risk. You should consider carefully the risks discussed below as well as those described
under </I>&ldquo;<I>Risk Factors</I>&rdquo; <I>of the prospectus supplement and the accompanying prospectus and in the documents
we have incorporated by reference herein and therein. In addition to the following risk factors, you should carefully consider
the risks, uncertainties and assumptions discussed in our Annual Report on Form 10-K/A for the year ended December 31, 2019 and
our Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, and in other documents that we subsequently file with
the SEC that update, supplement or supersede such information, which documents are incorporated by reference into this prospectus.
See &ldquo;Where You Can Find More Information.&rdquo; If any of the events actually occur, our business, financial condition or
results of operation may be materially and adversely affected. In such case, the trading price of our common stock could decline,
and investors could lose all or part of their investment. These risk factors may not identify all risks that we face, and our operations
could also be affected by factors that are not presently known to us or that we currently consider to be immaterial to our operations.
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Additional Risks Related to This Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>You will experience immediate and substantial dilution.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The offering price
per share in this offering will exceed the net tangible book value per share of our common stock outstanding prior to this offering.
Assuming that shares of our common stock are sold at a price of approximately $5.66 per share, based on the sale price of our common
stock on the NYSE American on February 12, 2021, for aggregate gross proceeds of $125,000,000, and after deducting commissions
and estimated offering expenses payable by us, you will experience immediate dilution of $2.25 per share, representing the difference
between our as adjusted net tangible book value per share as of September 30, 2020 after giving effect to this offering and the
assumed offering price, net of commissions and offering expenses. The vesting of restricted stock units and the exercise of stock
options and warrants will result in further dilution of your investment. See the section entitled &ldquo;Dilution&rdquo; below
for a more detailed illustration of the dilution you would incur if you participate in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="useofproceeds"></A><B>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue and sell
shares of our common stock having aggregate sales proceeds of up to $125,000,000 (which amount includes approximately $49.98 million
of gross proceeds from shares we have already sold pursuant to the sales agreement prior to the date of this amendment) from time
to time. Because there is no minimum offering amount required as a condition to close this offering, the actual total public offering
amount, commissions, expenses, and proceeds to us, if any, are not determinable at this time but will be reported in our periodic
reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to use the
net proceeds, if any, from this offering for the financing of possible acquisitions of companies and technologies, business expansions
and investments and for working capital and general corporate purposes, which may include the repayment, refinancing, redemption
or repurchase of indebtedness or capital stock. We do not have agreements or commitments for any specific acquisitions at this
time, other than those disclosed in our SEC filings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The amount and timing
of our actual expenditures for these purposes may vary significantly and will depend on a number of factors, including our future
revenue and cash generated by operations and other factors described under the heading &ldquo;Risk Factors&rdquo; in this amendment
and the prospectus supplement.&nbsp;&nbsp;Accordingly, our management will have broad discretion in applying the net proceeds of
this offering.&nbsp;Pending these uses, we intend to invest the net proceeds from this offering in short-term, investment-grade,
interest-bearing securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="dilution"></A><B>DILUTION</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.75pt">If you purchase shares
of our common stock in this offering, you will experience dilution to the extent of the difference between the public offering
price per share in this offering and our as adjusted net tangible book value per share immediately after this offering. Net tangible
book value per share is equal to the amount of our total tangible assets, less our total liabilities, divided by the number of
outstanding shares of our common stock. As of September 30, 2020, our net tangible book value was approximately $(6,559,739), or
$(0.57) per share based on 11,473,410 shares outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.75pt">After giving effect
to the sale of our common stock in the aggregate amount of $125,000,000 at an assumed public offering price of approximately $5.66
per share, after deducting the underwriting discount and estimated offering expenses payable by us, our as adjusted net tangible
book value as of September 30, 2020 would have been approximately $114,302,761. This represents an immediate increase in net tangible
book value of $3.98 per share to existing stockholders and an immediate decrease of $2.25 per share to new investors purchasing
shares of our common stock in this offering at the public offering price. The following table illustrates this per share dilution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; width: 64%">Assumed public offering price per share</TD><TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; width: 15%; text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: left">$</TD><TD STYLE="white-space: nowrap; width: 15%; text-align: right">5.66</TD><TD STYLE="white-space: nowrap; width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap">Net tangible book value per share as of September 30, 2020</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left">$</TD><TD STYLE="white-space: nowrap; text-align: right">(0.57</TD><TD STYLE="white-space: nowrap; text-align: left">)</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; text-align: left; padding-bottom: 1pt">Increase in net tangible book value per share after giving effect to this offering</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: right">3.98</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; white-space: nowrap; text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; text-align: left; padding-bottom: 1pt">As adjusted net tangible book value per share after giving effect to this offering</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; white-space: nowrap; text-align: right">3.41</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: right">3.41</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; text-align: left; padding-bottom: 2.5pt">Decrease per share to new investors in this offering</TD><TD STYLE="white-space: nowrap; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="white-space: nowrap; border-bottom: Black 2.5pt double; text-align: right">(2.25</TD><TD STYLE="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.75pt">The foregoing discussion
and table do not take into account further dilution to new investors that could occur upon the exercise of outstanding stock options
or warrants having a per share exercise price less than the per share offering price to the public in this offering. In addition,
we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient
funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity or
equity-linked securities, the issuance of these securities could result in further dilution to our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table and discussion
above are based on 11,473,410 shares outstanding as of September 30, 2020 and excludes, as of that date, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">950 shares of our common stock issuable upon the exercise of stock options outstanding as of September
30, 2020, at a weighted average exercise price of $578 per share;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">3,588,616 shares of our common stock issuable upon exercise of warrants outstanding as of September
30, 2020, at a weighted average exercise price of $5.91 per share; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD STYLE="text-align: justify">2,232 shares of our common stock reserved for issuance pursuant to the conversion of preferred
stock outstanding as of September 30, 2020.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="planofdist"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into
a sales agreement, as amended, with the sales agent, under which we may issue and sell shares of our common stock having an aggregate
gross sales price of up to $125,000,000 from time to time through the sales agent acting as such. Sales of our common stock, if
any, under this prospectus may be made in sales deemed to be &ldquo;at the market offerings&rdquo; as defined in Rule&nbsp;415
under the Securities Act.&nbsp;The sales agreement was filed as an exhibit to our Current Report on Form&nbsp;8-K filed with the
SEC on January 25, 2021, and the amendment to the sales agreement has been filed as an exhibit to our Current Report on Form 8-K
filed with the SEC on February 17, 2021, both of which are incorporated by reference in this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each time we wish to
issue and sell common stock, we will notify the sales agent of the number of shares to be issued, the dates on which such sales
are anticipated to be made, any minimum price below which sales may not be made and other sales parameters as we deem appropriate.
Once we have so instructed the sales agent, unless the sales agent declines to accept the terms of the notice, the sales agent
has agreed, subject to the terms and conditions of the sales agreement, to use its commercially reasonable efforts consistent with
its normal trading and sales practices to sell such shares up to the amount specified on such terms. We may instruct the sales
agent not to sell shares of common stock if the sales cannot be effected at or above the price designated by us in any such instruction.
We or the sales agent may suspend the offering of shares of common stock being made through the sales agent under the sales agreement
upon proper notice to the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay the sales
agent commissions for its services in acting as agent in the sale of our common stock. the sales agent will be entitled to compensation
at a commission rate equal to 3.25% of the aggregate gross sales price of the shares sold. Because there is no minimum offering
amount in this offering, the actual total public offering amount, commissions and proceeds to us, if any, are not determinable
at this time. We have also agreed to reimburse the sales agent for certain specified expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Settlement for sales
of common stock will occur on the second business day following the date on which any sales are made, or on some other date that
is agreed upon by us and the sales agent in connection with a particular transaction, in return for payment of the net proceeds
to us. There is no arrangement for funds to be received in an escrow, trust or similar arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the sale of the common stock on our behalf, the sales agent will be deemed to be an &ldquo;underwriter&rdquo; within the meaning
of the Securities Act and the compensation of the sales agent will be deemed to be underwriting commissions or discounts. We have
agreed to provide indemnification and contribution to the sales agent against certain civil liabilities, including liabilities
under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The offering of our
common stock pursuant to the sales agreement will terminate upon the earlier of (1)&nbsp;the sale of all shares of our common stock
having an aggregate offering price of&nbsp;$125,000,000, inclusive of the up to approximately $49,980,000 already sold thereunder
(unless the parties agree to extend, or increase the amount salable under, the sales agreement)&nbsp;or (2)&nbsp;termination of
the sales agreement as permitted therein. We may terminate the sales agreement at any time upon five days&rsquo; prior notice and
the sales agent&nbsp;may terminate the sales agreement at any time upon ten days&rsquo; prior notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
listed on the NYSE American under the symbol &ldquo;DPW.&rdquo; The transfer agent of our common stock is Computershare Trust Company,
N.A., 8742 Lucent Blvd., Suite 225, Highlands Ranch, CO 80129.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The sales agent and/or
its affiliates may in the future provide various investment banking and other financial services for us for which services they
may in the future receive customary fees.&nbsp;To the extent required by Regulation&nbsp;M promulgated under the Exchange Act,
the sales agent&nbsp;will not engage in any market making activities involving our common stock while the offering is ongoing under
this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This summary of the
material provisions of the sales agreement does not purport to be a complete statement of its terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The prospectus supplement,
as amended by this amendment, and the accompanying base prospectus in electronic format may be made available on a website maintained
by the sales agent, and the sales agent may distribute this amendment, the prospectus supplement and the accompanying base prospectus
electronically.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="legalmatters"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Olshan Frome Wolosky
LLP, New York, New York, as our counsel, will pass upon the validity of the common stock offered by this amendment and the prospectus
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">S-4</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 2px solid; font-size: 1pt; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>aultglobal_biglogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aultglobal_biglogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( ' !
MU0,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_
MQ "U$  " 0,# @0#!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q  ? 0 # 0$! 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($
M! ,$!P4$!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M7[">C3>'RMYXXU6'Q.]OE;BVTZVET2VNBF0IL'>&^O+9),;BNHV<LJ@X,1;
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MRQ_96Y^ G@\>NH^/O_5D>+J_3C1K]=4TBSNT^8S0KY@&.)57RYOIB0,0#U!
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M[.RN_;JY3D']F5<>\O=&"PE2M3]O.M"I'W+TE*/MFH2E)Q:C=ZSBFF]'G?\
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MM/M'TN[C6XOH9?EK_@M#^R)\#/V4_BK\-[GX2>.?'?BK6_CCH/B_XN>,]/\
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M1C_>_P#"4Z8XT[5(@-EOJ*Q*9!L8V]Y&KS6S866*'^\/_@FS\=]._9^_9_\
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M"',]O)(C*FXA5EBYQR?E=1CKOQ7@?Q"^#?BCPQX]\4_%+X;PMXATOQR=.O\
MX@_#7[3;V-W+X@TC3[?1U\<>"+JY$=C)KM_HEEIFF^(O#>J7>F66N1Z-INI6
M6KV6IVUW9Z[]B45C'@;*JG"U#A/,*N*S+ 86_P!6Q&(E3AC*#C.<Z$J56C3I
MPC+#JI*G3O!Q=']U4C.#:=+-L1#'SQ]&-.E4JV56G%2=*HO=YE)2DY>_*"G*
MTD^?WHM,^(%FDDF,36>J6-VC)FUU/3-3T>]R8T?,5KJEK97$J+O56EA1X]^4
M+;@0+T/A[7M2?%KI5_<N3DOY$C$8'&YV'RG 49=@,8!.*^SR@)R<^W3CZ<9_
MR: H'(Z^O?'I7YT_ C+77NN(,<L-S7]F\)AW7Y>WM^=4^;^_]7M?7DZ'L+BN
MNEIA*7/;?VL^6^FKCRW:>NG.K::L\8^'_P .9M'NEUG6"GV]%;[):HQ=;;?N
M#22L#L:7#855W"/[VX,-@\I_:P\%^*_&=[^SX?"^@W^MKX9^-A\0:\UC&)%T
MK11\*?BAI!U*\.1Y5K_:FK:98"3!!N;ZW3^(D?7]%?IF&X*R? \,XKA; JOA
ML%C:-2GB<0I1J8RK5K*"JXF=2<'3=:2IQBE[-4X0C&$*<8Q2/&>;8J684\QJ
M<M2K2DG"#35.,4FE!).ZC[SZW;U;;/A";X=>-W0!?#>I''&?(DY!Q@CY>^.,
M9ZUFS?#/QZV<>&-3Z?\ /%QZ<_=[<U^@-%? ?\0-R#_H<9S_ .6/_P RGL+B
MW&+;"X7I_P _NEO^GGD_O\CXJ_:&\"^,/$O[$7Q7\ :!X>U+5O&FL?##7=(T
MSPY9P^9J=_JER\OD6=O"2-\\H*[%W<_S\CC^%/Q&^R6J?\(AK *VL"L#;\JR
MPJI!&3R#D'!/(ZFOTQHKZ7/O#3*L_HY+0Q.89A0CDF64<KP[H?5DZM*C&G&-
M2M[2A->T:I*_(HQNW[IRX'B+$X%XGV="A/ZSB:F*ES^T]V=3EYHQY9KW?=6]
MWN<]X3@GM?#'AZUN8G@N;;1=*M[B&08DAFAL+>.6)QV>-U9&'9@170T45^A8
M>C'#8>AAXMRCAZ-*C&4K<THTH1@G*R2NU&[LDK[(\&I-SG.;23G*4K*]E=WL
MKZV6VNO<*\B^-OP?\/\ QN\"WG@W7I[K3)ENK76/#GB/35A.L>%/$^FEVTGQ
M!I/VB.6W>XM6EFM[FTN8Y+34],NK[2KZ*6ROKB-O7:*,1AZ.*H5<-B:4*V'K
MTYTJU*HN:%2G-.,X2752BVF%*K4HU(5:4Y4ZE.2G"<7:491=TT_)_P#!T/Q/
M\<? GXO_  ^N[NRU_P +7GB73;>-);;QIX,L+W4]"U&W+^7YM[I<0N-8\,7L
M61+>V6H1W>F6Z-FR\1:JD4C1>0SV6NS0/8Q6>J3VLK'?:+#<-;S$ *S/ %,<
MFT#:=R-@$#HPS_0:0&Z_Y_S_ /KJ$V\1;>5^;&,X&<?7&>PZ'L*_(<=X.995
MQ,JV6YMB\OI3;?U>=&.+C2BVKPI576H5>72R5:5637Q5&?9X?C7%0IQAB<%1
MQ,XV_>*HZ/,U:TI15.K%2WNX**[11^%'@O\ 9]^*WQ#N[6+2O"NIV.FW$R))
MKNLP3:;I-M$_,EQ]HNHU-R(E.6CLH[FX<[0D3YX_6OX$? _0O@GX7?2K"<:I
MK6J/'<^(==:+R'U"ZA#+#%!#ND,%A:!Y5M86D=\R22RL7E*I[BJA>F>?7FG5
M]3PKX?Y1PO5^MPG5Q^8\LH1Q>(C&"H1FN6:PU"/,J3G&\95)3JU.5RA&<83G
M&7EYOQ)C<WA[&488;#73="DY2=1Q:<?:U)>]4Y6DU%*$.9*7)S)-?CQ^VS\$
MOBS\0?VD+'Q1X,\ ^(O$7AV/X+>&M!?6--M!-9+K-KXW\=:A<Z:93(O^E066
MHV-S(F,"*YB8$Y('RDO[+G[08FW?\*F\7D=?^/!/3D?Z[TS^?I7]&E%<&<>&
M659UF>,S2OF.8TJN,J*I.G1^J^SBU"$+1Y\/.=K06\GYW.[+^,<;EV#H8.GA
M<+.&'IJG&<W64VE)2UY:D5?2VWK?6_\ /CHG[-/QZM]0L9)OA9XLB2.ZMW=G
ML5 55E3+$^;P% +'GH"3T./V2_: ^ 'A3X_^"X= UMVT;7]"NCK?@GQA9VXN
M-3\)>(5MW@%Y;PM) M]IU_:R2Z;KVC3RQV^KZ5<3VSO;W(M+RT]\HKU>'N!<
MJX?PV:8.-7$9AALWIT*6*HXU4'!PH*NE&*HTJ3][ZQ)MMN491C*#C)7//S3B
M/&YG7P>(<*>%K8&525">'=3F4JGLVV_:3GM[/:UFI24DT['X1>,?V??C)\-;
MNXMO$7A"ZUC3+9U^S^,/!\%[KGAR_@9B%N;B.&&75O#LD65:\M]=M8K>WW?Z
M-JNJ1))<CE+#2M5F8+'IU]*=H8*EM,[E1QD;%9CSD J2,]#FOZ!V4,,'Z] >
M>G<$=ZB-O$6#E?F P&& P'H& R/P(KX['^#665JTJF7YMB<#1G)R6'JX>&,5
M.]KQIU76H5.1):*I[26OO3:/8H<;XJ-.,<1@Z->:5G5A4G1<[=91<:L>;OR\
MJ?9;GXX^!?@9\2_&DUN+#PW?6%A(X#ZOK$4FGV$:?+ND$EPHEN  <[;6*XD)
M!39N!%?IC\(/@_HWPKTAX+:7^T=:OPO]K:N\9A:?:=R6UM#YDOV>SA) 1=YD
MF($L[$[(XO854+T'3C^M.KZCA;P[R7ABM]=A*KF&9).,,7B8PBJ"E'DG]6H0
MO&DYIM2G*=6KRR<8U%%M/Q\UXBQN:1=*2AA\.VFZ-)R;G9IKVLV[SLTFDHPC
M?5Q;29^,_P"TG\#?B]XJ_P""B/A_XF^'?A_XCUCP!;_LW0^%;CQ996?F:/#X
MB7Q=XDO3H\ESO&+T6EQ;W!BV_P"JGB8$[L5ZG;_"+XF+@GP=K2>_D,",Y[@Y
M[\].,BOU%HKRL^\*<HS_ #/%9IB<SS.C5Q51U)TJ'U3V46W>T?:8><[>LG_G
MT87BK%X7"T,)##8:5/#THTHRE[7F:C?65JB5VG;1)'YKVWPG^(\CHC>%-5!
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H@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>acmsm_smlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 acmsm_smlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,BXU /_; $,  @$! 0$!
M @$! 0(" @("! ," @("!00$ P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H*
M"@H&" L,"PH,"0H*"O_; $,! @(" @("!0,#!0H'!@<*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_  !$( $D
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M;-'L;7X<@W5XZDY\F.]U/=+]UA\H/;C)&?']M@Z=2\4WY,V4?W=SD/&'[/\
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MB-/%GC7PE]NU!=%FTE;C[?/%BSED222/;'(J\M&AW8W#& 0":T[3X8>"]/\
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7"B@ HH ** "B@ HH ** "B@ HH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
